Vinayak Venkataraman has Medical Oncology as his primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.
They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Duke University School Of Medicine and graduated in 2017 (around 7 years of experience). They are listed as doing telehealth appointments.
Vinayak Venkataraman
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-
Enter a starting address:
Additional Medical Specialties Include:
PEDIATRIC MEDICINE
Medical School: Duke University School Of Medicine
Graduation Year: 2017
The Primary Medical Specialty for Vinayak Venkataraman is listed as: Medical Oncology
Approximate Years of Experience: 7
PAC (PECOS ID)#: 7719251313
NPI #: 1437679610
NPI Created On: 06/20/2017
NPI Last Updated Listed as: 08/24/2023
Primary Taxonomy Code: 207RX0202X
License Number:
283026
Listed Gender: Male
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
75 Francis St
Boston, MA
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA
Dana-farber Cancer Institute, Inc.
20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine
22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology
View all 542 members of Dana-farber Cancer Institute, Inc. medical group